Viewing Study NCT05318534


Ignite Creation Date: 2025-12-25 @ 2:35 AM
Ignite Modification Date: 2026-06-24 @ 11:50 AM
Study NCT ID: NCT05318534
Status: RECRUITING
Last Update Posted: 2025-07-23
First Post: 2022-03-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Healthy Male and Female Subjects and Safety, Tolerability, Pharmacokinetics, and Pilot Efficacy Biomarkers in Subjects With Cold Agglutinin Disease
Sponsor: Gliknik Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None First in Man Study to Evaluate Initial Safety View
Keywords:

Keywords

Keyword Brief Keyword Text View
None complement-mediated diseases View